skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Topics covered in your multiple myeloma disease include:

  • Patient-based forecast methodology for multiple myeloma
  • Patients diagnosed with symptomatic and asymptomatic multiple myeloma, by country
  • Top three regimens used for first-line treatment of SCT-eligible multiple myeloma patients, by country
  • Absolute growth in incident cases of multiple myeloma in the US, Japan, and five major EU markets, by country, 2014–34
  • Age-specific trends in incident cases of multiple myeloma in the US, Japan, and five major EU markets, by age group, 2014–34
  • Farydak for multiple myeloma – SWOT analysis
  • Datamonitor Healthcare’s drug assessment summary of Kyprolis in multiple myeloma
  • Keytruda Phase III trials in multiple myeloma